Gut & Liver

Your Liver Is Talking. Here's What Your Labs Aren't Telling You.

For anyone who has been told their liver enzymes are "a little elevated" and sent home without an explanation.

Your Liver Is Talking. Here's What Your Labs Aren't Telling You.

I want to tell you something that most people leave their doctor’s office not knowing.

You can have significant liver disease with no symptoms. No pain. No yellowing skin. No dramatic sign that anything is wrong. Just a number on a lab report that gets flagged, mentioned in passing, and then filed away under “something to keep an eye on.”

I’ve had patients come to me who were told exactly that — years ago. One woman I’m thinking of had elevated liver enzymes flagged at 38, was told to cut back on alcohol even though she barely drank, and wasn’t offered any further investigation. She came to see me at 44 with fibrosis showing on imaging. Six years of watching. Six years that mattered.

That number on your lab report is not nothing. It’s your liver trying to tell you that the metabolic pressure you’ve been under has started to leave a mark.

The condition is called MASLD. You may have heard the older name: nonalcoholic fatty liver disease, or NAFLD. In 2023, a global consortium of medical societies formally renamed and redefined it — because the new name tells you exactly what this disease actually is. Metabolic dysfunction-associated steatotic liver disease. The liver problem that comes from metabolic dysfunction. Not from drinking. Not from bad luck. From the same interconnected system we’ve been talking about throughout this series.

This is not a rare diagnosis. It affects somewhere between 25 and 30 percent of the general population. Most of those people have no idea [1].

And before you decide this doesn’t apply to you because you eat reasonably well and don’t drink much — MASLD can and does develop in people with normal weight, normal cholesterol, and no obvious risk factors. If you have insulin resistance, if your blood pressure has been creeping up, if you’ve been told your triglycerides are high — your liver is in this conversation whether or not anyone has put it there [2].

This is the opening of a longer article.

The full piece — the mechanisms, the labs to ask for, and what to do about it — is free to read on our newsletter.

Continue reading on Substack →

Sources & Research

Every claim in this article is grounded in peer-reviewed research. DOI links open the original studies.

  1. Rinella ME, Lazarus JV, Ratziu V, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Annals of Hepatology. 2024;29(1):101133. doi:10.1016/j.aohep.2023.101133

  2. European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Journal of Hepatology. 2024;81(3):492–542. doi:10.1016/j.jhep.2024.04.031

  3. Cusi K, Isaacs S, Barb D, et al. American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings. Endocrine Practice. 2022;28(5):528–562. doi:10.1016/j.eprac.2022.03.010

  4. Chen VL, Morgan TR, Rotman Y, Patton HM, Cusi K, Kanwal F, Kim WR. Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance. Hepatology. 2025;81(1):312–320. doi:10.1097/HEP.0000000000001112

Ready to Explore Your Health?

This article touches on topics covered in our functional medicine consultations.

Keep Reading

More from the Journal